Ciclesonide study for breathing support in preterm infants
Part of Genetic & congenital, Lungs & breathing clinical trials.
This study tests an inhaled anti-inflammatory drug called ciclesonide for premature babies who need a breathing tube. It aims to see if the drug can help their lungs heal and reduce the need for steroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 23 weeks and 29 weeks and 6 days of pregnancy.
- Your baby is between 8 and 35 days old.
- Your baby is on a breathing machine with a tube.
- Your baby has not received dexamethasone in the last 5 days.
- Your baby has no major birth defects, active infections, or severe bleeding in the brain.
- Your baby's blood sugar is stable and not too high.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called zelpultide alfa in very premature babies who are at high risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease. The goal is to see if it can help prevent or lessen lung problems compared to standard care alone.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
This trial tests a new treatment to help very premature babies (born at 22 to nearly 29 weeks) who still need a breathing machine and extra oxygen at 1–2 weeks old. The goal is to see if it can improve their lung health and reduce the need for breathing support.
This study tests whether a steroid medicine called dexamethasone can help prevent a serious lung problem in very premature babies who need a breathing machine for a long time. It may help babies who are still on the machine after two weeks and need high levels of oxygen.
This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.
Hear when a new Bronchopulmonary Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.